A detailed history of Citigroup Inc transactions in Staar Surgical CO stock. As of the latest transaction made, Citigroup Inc holds 64,607 shares of STAA stock, worth $1.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,607
Previous 33,821 91.03%
Holding current value
$1.7 Million
Previous $1.61 Million 49.07%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$29.97 - $47.42 $922,656 - $1.46 Million
30,786 Added 91.03%
64,607 $2.4 Million
Q2 2024

Aug 12, 2024

BUY
$38.07 - $52.25 $154,868 - $212,553
4,068 Added 13.67%
33,821 $1.61 Million
Q1 2024

May 10, 2024

BUY
$27.67 - $39.61 $43,109 - $61,712
1,558 Added 5.53%
29,753 $1.14 Million
Q4 2023

Feb 09, 2024

BUY
$30.6 - $43.78 $276,379 - $395,420
9,032 Added 47.13%
28,195 $879,000
Q3 2023

Nov 09, 2023

BUY
$39.39 - $58.12 $95,875 - $141,464
2,434 Added 14.55%
19,163 $769,000
Q2 2023

Aug 10, 2023

BUY
$50.45 - $72.82 $636,779 - $919,134
12,622 Added 307.33%
16,729 $879,000
Q1 2023

May 11, 2023

SELL
$51.25 - $79.34 $104,447 - $161,694
-2,038 Reduced 33.17%
4,107 $262,000
Q4 2022

Feb 09, 2023

SELL
$46.82 - $76.2 $650,423 - $1.06 Million
-13,892 Reduced 69.33%
6,145 $298,000
Q3 2022

Nov 10, 2022

SELL
$70.55 - $111.58 $490,816 - $776,262
-6,957 Reduced 25.77%
20,037 $1.41 Million
Q2 2022

Aug 10, 2022

BUY
$50.24 - $80.48 $109,020 - $174,641
2,170 Added 8.74%
26,994 $1.92 Million
Q1 2022

May 12, 2022

SELL
$57.98 - $93.5 $4,406 - $7,106
-76 Reduced 0.31%
24,824 $1.98 Million
Q4 2021

Feb 10, 2022

SELL
$88.02 - $127.79 $9.35 Million - $13.6 Million
-106,208 Reduced 81.01%
24,900 $2.27 Million
Q3 2021

Nov 10, 2021

BUY
$122.75 - $162.68 $16.1 Million - $21.3 Million
131,108 New
131,108 $16.9 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.26B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.